MedTrace Logo

EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.

NCT07006090 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-03-05

No results posted yet for this study

Summary

The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.

Conditions

  • Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® Scanner
  • Whatever the Disease Area

Interventions

DEVICE

Histolog Scanner

Histolog Scanner intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture.

Sponsors & Collaborators

  • SamanTree Medical SA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-04
Primary Completion
2036-03-31
Completion
2036-04-30
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07006090 on ClinicalTrials.gov